Genenta Science (GNTA) News Today $3.83 +0.05 (+1.32%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GNTA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA) Short Interest UpdateAugust 7, 2025 | marketbeat.comAllianz SE Purchases 130,300 Shares of Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA)August 5, 2025 | marketbeat.comGenenta Science (NASDAQ:GNTA) Stock Price Down 1.3% - Here's WhyJuly 11, 2025 | marketbeat.comGenenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival SignalsJuly 1, 2025 | globenewswire.comGenenta Science S.p.A. (NASDAQ:GNTA) Short Interest Down 31.0% in MayJune 17, 2025 | marketbeat.comGenenta Science S.p.A. (NASDAQ:GNTA) Short Interest UpdateJune 4, 2025 | marketbeat.comGNTA Genenta Science S.p.A.May 30, 2025 | seekingalpha.comGenenta Science (NASDAQ:GNTA) Stock Price Up 7% - Here's WhyMay 16, 2025 | marketbeat.comGenenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapiesMay 7, 2025 | globenewswire.comGenenta Science S.p.A. (NASDAQ:GNTA) Short Interest Up 84.6% in AprilMay 1, 2025 | marketbeat.comGenenta Science (NASDAQ:GNTA) Shares Down 0.3% - Time to Sell?April 23, 2025 | marketbeat.comGenenta Showcases Strategic Vision at Premier Biotech Forum in QatarApril 15, 2025 | globenewswire.comAllianz SE Makes New $444,000 Investment in Genenta Science S.p.A. (NASDAQ:GNTA)April 1, 2025 | marketbeat.comGenenta Science announces EUR 20M financing to expand pipelineMarch 21, 2025 | markets.businessinsider.comGenenta Science Secures €20 Million Convertible Bond Financing for Oncology ResearchMarch 19, 2025 | tipranks.comGenenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival RatesMarch 19, 2025 | globenewswire.comShort Interest in Genenta Science S.p.A. (NASDAQ:GNTA) Declines By 40.0%March 16, 2025 | marketbeat.comGenenta Science S.p.A. (NASDAQ:GNTA) Short Interest Down 26.5% in FebruaryMarch 3, 2025 | marketbeat.comShort Interest in Genenta Science S.p.A. (NASDAQ:GNTA) Expands By 30.8%February 17, 2025 | marketbeat.comIs Genenta Science S.p.A. (GNTA) the Best Italian Stock to Buy in 2025?February 13, 2025 | msn.comGenenta Science (NASDAQ:GNTA) Shares Up 1.3% - Here's What HappenedFebruary 11, 2025 | marketbeat.comGenenta Science SpA ADRFebruary 1, 2025 | investing.comTOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCEJanuary 28, 2025 | prnewswire.comGenenta Science (NASDAQ:GNTA) Stock Price Down 1.3% - Time to Sell?January 18, 2025 | marketbeat.comGenenta Science (NASDAQ:GNTA) Shares Down 1.3% - Here's WhyJanuary 18, 2025 | marketbeat.comGenenta Science announces amendment to pact with AGC BiologicsJanuary 10, 2025 | finance.yahoo.comGenenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy ManufacturingJanuary 9, 2025 | globenewswire.comITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCEJanuary 8, 2025 | prnewswire.comGenenta Science Enhances Manufacturing Agreement with AGC BiologicsJanuary 1, 2025 | markets.businessinsider.comGenenta Science S.p.A. (NASDAQ:GNTA) Sees Large Increase in Short InterestDecember 27, 2024 | marketbeat.comGenenta Science Updates ATM Sales Agreement with New AgentDecember 20, 2024 | tipranks.comGenenta Science (NASDAQ:GNTA) Stock Price Up 2.4% - Here's WhyDecember 13, 2024 | marketbeat.comGenenta Science (NASDAQ:GNTA) Stock Price Down 4.9% - Should You Sell?November 21, 2024 | marketbeat.comGenenta Science S.p.A. (NASDAQ:GNTA) Sees Large Growth in Short InterestOctober 26, 2024 | marketbeat.comGenenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”October 23, 2024 | globenewswire.comGenenta Science (NASDAQ:GNTA) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comGenenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insidersOctober 11, 2024 | finance.yahoo.comBuy Rating Affirmed for Genenta Science Amid Promising Developments in Gene Therapy TrialsOctober 4, 2024 | markets.businessinsider.comGenenta Science's (GNTA) Buy Rating Reaffirmed at HC WainwrightOctober 2, 2024 | marketbeat.comGenenta Secures Approval for Innovative Trial for Metastatic Renal Cell CancerOctober 2, 2024 | globenewswire.comGenenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative BiotechSeptember 30, 2024 | finance.yahoo.comAlTi Global Inc. Acquires Shares of 200,288 Genenta Science S.p.A. (NASDAQ:GNTA)September 26, 2024 | marketbeat.comGenenta Science (NASDAQ:GNTA) Stock Price Up 5.4%September 24, 2024 | marketbeat.comGenenta Science S.p.A. (NASDAQ:GNTA) Sees Significant Decrease in Short InterestSeptember 2, 2024 | marketbeat.comShort Interest in Genenta Science S.p.A. (NASDAQ:GNTA) Rises By 47.1%June 29, 2024 | marketbeat.com7 Penny Biotech Stocks to Triple Your InvestmentMay 28, 2024 | investorplace.comAnalysts Conflicted on These Healthcare Names: Cingulate Inc (CING) and Genenta Science SpA Sponsored ADR (GNTA)May 10, 2024 | markets.businessinsider.comGenenta Science (Nasdaq:GNTA) HeadlineTrading was temporarily halted for "GNTA" at 10:05 AM with a stated reason of "LULD pause."...May 9, 2024 | marketbeat.comGenenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderMay 6, 2024 | finance.yahoo.comGenenta Welcomes New Directors John L. Cantello, Lauren H.May 6, 2024 | globenewswire.com Get Genenta Science News Delivered to You Automatically Sign up to receive the latest news and ratings for GNTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNTA Media Mentions By Week GNTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNTA News Sentiment▼0.470.99▲Average Medical News Sentiment GNTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNTA Articles This Week▼40▲GNTA Articles Average Week Get the Latest News and Ratings for GNTA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genenta Science and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Puma Biotechnology News Today Lexeo Therapeutics News Today Allogene Therapeutics News Today Prima BioMed News Today Alpha Teknova News Today Adherex Technologies News Today Editas Medicine News Today Alector News Today ProQR Therapeutics News Today Annexon News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNTA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access